Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

93 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Human Herpesvirus 6 Encephalitis Following Axicabtagene Ciloleucel Treatment for Refractory Diffuse Large B Cell Lymphoma.
Shah M, Kuhnl A, Shields G, Sudhanva M, Metaxa V, Wong S, Yallop D, Patten P, Inam S, Hockings C, Stewart O, Benjamin R, Cuthill K, Pagliuca A, Potter V, Sanderson R. Shah M, et al. Among authors: metaxa v. Hemasphere. 2021 Feb 17;5(3):e535. doi: 10.1097/HS9.0000000000000535. eCollection 2021 Mar. Hemasphere. 2021. PMID: 33623881 Free PMC article. No abstract available.
End-of-Life Issues in Intensive Care Units.
Metaxa V. Metaxa V. Semin Respir Crit Care Med. 2021 Feb;42(1):160-168. doi: 10.1055/s-0040-1710370. Epub 2020 Aug 9. Semin Respir Crit Care Med. 2021. PMID: 32772354
Correction to: ICU-outcomes in CAR-T patients-A single centre experience.
Materski T, John M, Pirani T, Benjamin R, Kuhnl A, Potter V, Sanderson R, Metaxa V. Materski T, et al. Among authors: metaxa v. Intensive Care Med Exp. 2021 Feb 18;9(1):9. doi: 10.1186/s40635-021-00370-2. Intensive Care Med Exp. 2021. PMID: 33599849 Free PMC article. No abstract available.
UCART19, a first-in-class allogeneic anti-CD19 chimeric antigen receptor T-cell therapy for adults with relapsed or refractory B-cell acute lymphoblastic leukaemia (CALM): a phase 1, dose-escalation trial.
Benjamin R, Jain N, Maus MV, Boissel N, Graham C, Jozwik A, Yallop D, Konopleva M, Frigault MJ, Teshima T, Kato K, Boucaud F, Balandraud S, Gianella-Borradori A, Binlich F, Marchiq I, Dupouy S, Almena-Carrasco M, Pannaux M, Fouliard S, Brissot E, Mohty M; CALM Study Group. Benjamin R, et al. Lancet Haematol. 2022 Nov;9(11):e833-e843. doi: 10.1016/S2352-3026(22)00245-9. Epub 2022 Oct 10. Lancet Haematol. 2022. PMID: 36228643 Clinical Trial.
Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies.
Benjamin R, Graham C, Yallop D, Jozwik A, Mirci-Danicar OC, Lucchini G, Pinner D, Jain N, Kantarjian H, Boissel N, Maus MV, Frigault MJ, Baruchel A, Mohty M, Gianella-Borradori A, Binlich F, Balandraud S, Vitry F, Thomas E, Philippe A, Fouliard S, Dupouy S, Marchiq I, Almena-Carrasco M, Ferry N, Arnould S, Konto C, Veys P, Qasim W; UCART19 Group. Benjamin R, et al. Lancet. 2020 Dec 12;396(10266):1885-1894. doi: 10.1016/S0140-6736(20)32334-5. Lancet. 2020. PMID: 33308471 Clinical Trial.
Secondary HLH is uncommon in severe COVID-19.
Wood H, Jones JR, Hui K, Mare T, Pirani T, Galloway J, Metaxa V, Benjamin R, Rutherford A, Cain S, Kulasekararaj AG. Wood H, et al. Among authors: metaxa v. Br J Haematol. 2020 Sep;190(5):e283-e285. doi: 10.1111/bjh.16934. Epub 2020 Aug 10. Br J Haematol. 2020. PMID: 32526046 Free PMC article. No abstract available.
Palliative care interventions in intensive care unit patients.
Metaxa V, Anagnostou D, Vlachos S, Arulkumaran N, Bensemmane S, van Dusseldorp I, Aslakson RA, Davidson JE, Gerritsen RT, Hartog C, Curtis JR. Metaxa V, et al. Intensive Care Med. 2021 Dec;47(12):1415-1425. doi: 10.1007/s00134-021-06544-6. Epub 2021 Oct 15. Intensive Care Med. 2021. PMID: 34652465
93 results